CASI Pharmaceuticals, Inc. (CASIF)

CIK 1962738 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CASI Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 20266-K0001104659-26-104455
Aug 14, 20266-K0001104659-26-096404
Aug 13, 20266-K0001104659-26-095969
Jul 15, 20266-K0001104659-26-083702
Jun 29, 20266-K0001104659-26-078452
Jun 23, 202625-NSE0001354457-26-000606
Jun 2, 20266-K0001104659-26-069177
May 18, 2026SCHEDULE 13D/A0001104659-26-063233
May 15, 202620-F0001104659-26-061632
Apr 28, 2026D0001962738-26-000004
Apr 23, 202630001104659-26-047080
Apr 21, 2026NT 20-F0001104659-26-045634
Apr 20, 20266-K0001104659-26-045529
Apr 20, 20266-K0001104659-26-045275
Apr 20, 202630001104659-26-045617
Apr 16, 202630001104659-26-044404
Apr 15, 20266-K0001104659-26-043516
Apr 13, 202630001104659-26-042658
Apr 7, 202630001104659-26-040417
Apr 3, 202630001104659-26-039647
Apr 3, 202630001104659-26-039652
Mar 27, 202630001104659-26-035726
Mar 25, 202630001104659-26-034136
Mar 23, 2026SCHEDULE 13D/A0001104659-26-032956
Mar 18, 202630001193125-26-114091